SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-041575
Filing Date
2021-08-05
Accepted
2021-08-05 16:06:13
Documents
14
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arwr-8k_20210805.htm   iXBRL 8-K 38938
2 EX-99.1 arwr-ex991_6.htm EX-99.1 234207
3 GRAPHIC gtryd511pd0a000001.jpg GRAPHIC 4631
  Complete submission text file 0001564590-21-041575.txt   421664

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arwr-20210805.xsd EX-101.SCH 5721
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20210805_lab.xml EX-101.LAB 19335
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20210805_pre.xml EX-101.PRE 11513
7 EXTRACTED XBRL INSTANCE DOCUMENT arwr-8k_20210805_htm.xml XML 3559
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 211148133
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences